Press/Media
- 225 - 250 out of 9,489 results
Search results
-
Personalized Cancer Vaccine Proves Promising in a Phase 1 Trial at Mount Sinai
Marron, T., Friedlander, P. & Bhardwaj, N.
21/03/25
1 item of Media coverage
Press/Media
-
Personalized Cancer Vaccine Proves Promising in a Phase 1 Trial at Mount Sinai
Marron, T., Friedlander, P. & Bhardwaj, N.
21/03/25
1 item of Media coverage
Press/Media
-
Personalized Cancer Vaccine Proves Promising in a Phase 1 Trial at Mount Sinai
Marron, T., Friedlander, P. & Bhardwaj, N.
21/03/25
1 item of Media coverage
Press/Media
-
Personalized Cancer Vaccine Proves Promising in a Phase 1 Trial at Mount Sinai
Marron, T., Friedlander, P. & Bhardwaj, N.
21/03/25
1 item of Media coverage
Press/Media
-
Personalized Cancer Vaccine Proves Promising in a Phase 1 Trial at Mount Sinai
Marron, T., Friedlander, P. & Bhardwaj, N.
21/03/25
1 item of Media coverage
Press/Media
-
Personalized Cancer Vaccine Proves Promising in a Phase 1 Trial at Mount Sinai
Marron, T., Friedlander, P. & Bhardwaj, N.
21/03/25
1 item of Media coverage
Press/Media
-
Personalized Cancer Vaccine Proves Promising in a Phase 1 Trial at Mount Sinai
Marron, T., Friedlander, P. & Bhardwaj, N.
21/03/25
1 item of Media coverage
Press/Media
-
Personalized Cancer Vaccine Proves Promising in a Phase 1 Trial at Mount Sinai
Marron, T., Friedlander, P. & Bhardwaj, N.
21/03/25
1 item of Media coverage
Press/Media
-
Personalized Cancer Vaccine Proves Promising in a Phase 1 Trial at Mount Sinai
Marron, T., Friedlander, P. & Bhardwaj, N.
21/03/25
1 item of Media coverage
Press/Media
-
Personalized Cancer Vaccine Proves Promising in a Phase 1 Trial at Mount Sinai
Marron, T., Friedlander, P. & Bhardwaj, N.
21/03/25
1 item of Media coverage
Press/Media
-
Personalized Cancer Vaccine Proves Promising in a Phase 1 Trial at Mount Sinai
Marron, T., Friedlander, P. & Bhardwaj, N.
21/03/25
1 item of Media coverage
Press/Media
-
Personalized Cancer Vaccine Proves Promising in a Phase 1 Trial at Mount Sinai
Marron, T., Friedlander, P. & Bhardwaj, N.
21/03/25
1 item of Media coverage
Press/Media
-
Personalized Cancer Vaccine Proves Promising in a Phase 1 Trial at Mount Sinai
Marron, T., Friedlander, P. & Bhardwaj, N.
21/03/25
1 item of Media coverage
Press/Media
-
Personalized Cancer Vaccine Proves Promising in a Phase 1 Trial at Mount Sinai
Marron, T., Friedlander, P. & Bhardwaj, N.
21/03/25
1 item of Media coverage
Press/Media
-
Personalized Cancer Vaccine Proves Promising in a Phase 1 Trial at Mount Sinai
Marron, T., Friedlander, P. & Bhardwaj, N.
21/03/25
1 item of Media coverage
Press/Media
-
-
Findings from Stanford University Yields New Findings on Life Science (Deciphering the Impact of Genomic Variation On Function)
20/03/25
1 item of Media coverage
Press/Media
-
Understanding Esophageal Squamous Cell Carcinoma: Pathophysiology, Knowledge Gaps, and Promising Developments
19/03/25
1 item of Media coverage
Press/Media
-
Mount Sinai Leads Phase 3 Trial in Myelofibrosis Treatment
19/03/25
1 item of Media coverage
Press/Media
-
Mount Sinai Leads Phase 3 Trial in Myelofibrosis Treatment
19/03/25
1 item of Media coverage
Press/Media
-
Personalized Cancer Vaccine Proves Promising in a Phase 1 Trial at Mount Sinai
Marron, T., Friedlander, P. & Bhardwaj, N.
17/03/25
1 item of Media coverage
Press/Media
-
Personalized Cancer Vaccine Proves Promising In Phase 1 Trial At Mount Sinai
Marron, T., Friedlander, P. & Bhardwaj, N.
17/03/25
1 item of Media coverage
Press/Media
-
Personalized Cancer Vaccine Proves Promising in a Phase 1 Trial at Mount Sinai
Marron, T., Friedlander, P. & Bhardwaj, N.
17/03/25
1 item of Media coverage
Press/Media
-
Weekly: Karyopharm Therapeutics (KPTI: $6.75) falls for a fourth consecutive week, a four-week fall of 27%; -14c [2.0%] Vol Index 1.3 [1 is avg]
15/03/25
1 item of Media coverage
Press/Media
-
-NTx Establishes Scientific Advisory Board with Distinguished Leaders in Oncology
14/03/25
1 item of Media coverage
Press/Media